Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction
NCT: NCT04920396 · WITHDRAWN
NCT IDNCT04920396
StatusWITHDRAWN
Start Date2021-06-08
Completion2026-01-19
SponsorAston University (OTHER)
First posted
Last updated
Brief Summary
This study is to evaluate the effectiveness of E\>EYE intense regulated pulsed light (IRPL) treatment compared to the current standard of care using a daily warm compress
Frequently Asked Questions
What is Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction?
Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction is a clinical trial registered under NCT04920396. Current status: WITHDRAWN.
What is the status of NCT04920396?
The current status of NCT04920396 (Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction) is: WITHDRAWN.
When did Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction start?
Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction started on 2021-06-08.
Related Devices
K192521Intense Pulsed Light Treatment SystemShangdong Huamei Technology Co., Ltd.
K230816Intense Pulsed Light Treatment SystemShangdong Huamei Technology Co., Ltd.
K242440Intense Pulsed Light Treatment System (LK-PT)Nanjing Bestview Laser S&T Co., Ltd.
K193500Stellar M22 for Intense Pulsed Light (IPL) and Laser SystemLumenis, Ltd.
K212881Intense Pulsed Light (IPL) SystemShenzhen Fansizhe Science and Technology Co., Ltd.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.